Fibroblast Growth Factor Receptor 3 Gene: Regulation by Serum Response Factor

Molecular Endocrinology

Volumn 18, Issue 1, 2004, Pages 241-251

  Reinhold, Martina I ^a   McEwen, Donald G ^b   Naski, Michael C ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR 3; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR;

ARTICLE; CHROMATIN; CONSENSUS SEQUENCE; CONTROLLED STUDY; EMBRYO; FEMALE; GENE CONTROL; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CHONDROCYTES; GENE EXPRESSION REGULATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; SERUM RESPONSE FACTOR; TEMPLATES, GENETIC; TRANSCRIPTION, GENETIC;

EID: 0346656461     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0312     Document Type: Article

References (54)

1. Ornitz DM, Waksman G 1997 Fibroblast growth factor receptors. In: Ziegler TR, Pierce GF, Hemdon DN, eds. Growth factors and wound healing: basic science and potential clinical applications. New York: Springer-Verlag; 151-174
2. Xu X, Weinstein M, Li C, Naski M, Cohen RI, Ornitz DM, Leder P, Deng C 1998 Fibroblast growth factor receptor 2 (FGFR2)-mediated regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125: 753-765
3. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon W 1995 Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9:165-172
4. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S 1994 Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 8:98-103
5. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM 1996 Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12:390-397
6. Li Y, Mangasarian K, Mansukhani A, Basilico C 1997 Activation of FGF receptors by mutations in the transmembrane domain. Oncogene 14:1397-1406
7. Webster MK, D'Avis PY, Robertson SC, Donoghue DJ 1996 Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol Cell Biol 16:4081-4087
8. Webster MK, Donoghue DJ 1996 Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J 15:520-527
9. Naski MC, Wang Q, Xu J, Ornitz DM 1996 Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 13:233-237
10. Wang Q, Green RP, Zhao G, Ornitz DM 2001 Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development 128:3867-3876
11. Naski MC, Colvin JS, Coffin JD, Ornitz DM 1998 Repression of hedgehog signaling and BMP4 expression by fibroblast growth factor receptor 3 in growth plate cartilage of transgenic mice. Development 125:4977-4988
12. Peters K, Ornitz DM, Werner S, Williams L 1993 Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 155:423-430
13. lseki S, Wilkie AO, Morriss-Kay GM 1999 Fgfr1 and Fgfr2 have distinct differentiation-and proliferation-related roles in the developing mouse skull vault. Development 126:5611-5620
14. Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L, Le Merrer M, Munnich A, Vekemans M, Bonaventure J 1998 Spatio-temporal expression of Fgfr 1, 2 and 3 genes during human embryo-fetal ossification. Mech Dev 77:19-30
15. McEwen DG, Ornitz DM 1998 Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer by Sp1 family transcription factors. J Biol Chem 273: 5349-5357
16. McEwen DG, Green RP, Naski MC, Towler DA, Ornitz DM 1999 Fibroblast growth factor receptor 3 gene transcription is suppressed by cyclic adenosine 3′, 5′-monophosphate: identification of a chondrocytic regulatory element. J Biol Chem 274:30934-30942
17. Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G, Richardson JA, Nordheim A, Olson EN 2002 Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci USA 99:14855-14860
18. Miralles F, Czernichow P, Ozaki K, Itoh N, Scharfmann R 1999 Signaling through fibroblast growth factor receptor 2b plays a key role in the development of the exocrine pancreas. Proc Natl Acad Sci USA 96:6267-6272
19. Sotiropoulos A, Gineitis D, Copeland J, Treisman R 1999 Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98:159-169
20. Hill CS, Wynne J, Treisman R 1995 The Rho family GT-Pases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159-1170
21. Gineitis D, Treisman R 2001 Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem 276:24531-24539
22. Brown PD, Benya PD 1988 Alterations in chondrocyte cytoskeletal architecture during phenotypic modulation by retinoic acid and dihydrocytochalasin B-induced reexpression. J Cell Biol 106:171-179
23. Benya PD, Brown PD, Padilla SR 1988 Microfilament modification by dihydrocytochalasin B causes retinoic acid-modulated chondrocytes to reexpress the differentiated collagen phenotype without a change in shape. J Cell Biol 106:161-170
24. Benya PD, Shaffer JD 1982 Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30:215-224
25. Daniels K, Solursh M 1991 Modulation of chondrogenesis by the cytoskeleton and extracellular matrix. J Cell Sci 100:249-254
26. Tacchetti C, Tavella S, Dozin B, Quarto R, Robino G, Cancedda R 1992 Cell condensation in chondrogenic differentiation. Exp Cell Res 200:26-33
27. Shakibaei M 1998 Inhibition of chondrogenesis by integrin antibody in vitro. Exp Cell Res 240:95-106
28. Zanetti NC, Solursh M 1984 Induction of chondrogenesis in limb mesenchymal cultures by disruption of the actin cytoskeleton. J Cell Biol 99:115-123
29. Loty S, Forest N, Boulekbache H, Sautier JM 1995 Cytochalasin D induces changes in cell shape and promotes in vitro chondrogenesis: a morphological study. Biol Cell 83:149-161
30. Belaguli NS, Schildmeyer LA, Schwartz RJ 1997 Organization and myogenic restricted expression of the murine serum response factor gene. A role for autoregulation. J Biol Chem 272:18222-18231
31. Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, Nordhelm A 1998 Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J 17:6289-6299
32. Miranti CK, Ginty DD, Huang G, Chatila T, Greenberg ME 1995 Calcium activates serum response factor-dependent transcription by a Ras-and Elk-independent mechanism that involves a Ca2+/calmodulin-dependent kinase. Mol Cell Biol 15:3672-3684
33. Firulli AB, Olson EN 1997 Modular regulation of muscle gene transcription: a mechanism for muscle cell diversity. Trends Genet 13:364-369
34. Wei L, Zhou W, Croissant JD, Johansen FE, Prywes R, Balasubramanyam A, Schwartz RJ 1998 RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation. J Biol Chem 273:30287-30294
35. Solursh M, Jensen KL, Singley CT, Linsenmayer TF, Reiter RS 1982 Two distinct regulatory steps in cartilage differentiation. Dev Biol 94:311-325
36. Oberlender SA, Tuan RS 1994 Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120:177-187
37. Hall BK, Miyake T 1992 The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis. Anat Embryol (Berl) 186:107-124
38. Hall BK, Miyake T 1995 Divide, accumulate, differentiate: cell condensation in skeletal development revisited. Int J Dev Biol 39:881-893
39. Dalton S, Treisman R 1994 Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 76:411
40. Spencer JA, Baron MH, Olson EN 1999 Cooperative transcriptional activation by serum response factor and the high mobility group protein SSRP1. J Biol Chem 274:15686-15693
41. MacLellan WR, Lee TC, Schwartz RJ, Schneider MD 1994 Transforming growth factor-beta response elements of the skeletal α-actin gene. Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J Biol Chem 269:16754-16760
42. Carson JA, Fillmore RA, Schwartz RJ, Zimmer WE 2000 The smooth muscle gamma-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor. J Biol Chem 275: 39061-39072
43. Chen CY, Schwartz RJ 1996 Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac a-actin gene transcription. Mol Cell Biol 16: 6372-6384
44. Pellegrini L, Tan S, Richmond TJ 1995 Structure of serum response factor core bound to DNA. Nature 376:490-498
45. Chen CY, Schwartz RJ 1997 Competition between negative acting YY1 versus positive acting serum response factor and tinman homologue Nkx-2.5 regulates cardiac alpha-actin promoter activity. Mol Endocrinol 11:812-822
46. Lee TC, Shi Y, Schwartz RJ 1992 Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal a-actin transcription in embryonic myoblasts. Proc Natl Acad Sci USA 89:9814-9818
47. Natesan S, Gilman M 1995 YY1 facilitates the association of serum response factor with the c-fos serum response element. Mol Cell Biol 15:5975-5982
48. Wilson TE, Fahrner TJ, Milbrandt J 1993 The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol 13:5794-5804
49. Parker KL, Schimmer BP 1995 Transcriptional regulation of the genes encoding the cytochrome P-450 steroid hydroxylases. Vitam Horm 51:339-370
50. Towler DA, Rodan GA 1995 Identification of a rat osteocalcin promoter 3′, 5′-cyclic adenosine monophosphate response region containing two PuGGTCA steroid hormone receptor binding motifs. Endocrinology 136: 1089-1096
51. Bernier SM, Desjardins J, Sullivan AK, Goltzman D 1990 Establishment of an osseous cell line from fetal rat calvaria using an immunocytolytic method of cell selection: characterization of the cell line and of derived clones. J Cell Physiol 145:274-285
52. Grigoriadis AE, Heersche JNM, Aubin JE 1990 Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line. Dev Biol 142: 313-318
53. Rupp RAW, Snider L, Weintraub H 1994 Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev 8:1311-1323
54. Dignam JD, Lebovitz RM, Roeder RG 1983 Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489